This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Argus Research Keeps Their Buy Rating on Intercontinental Exchange (ICE)

Tipranks - Tipranks - Sat May 30, 11:08AM CDT

Argus Research analyst Kevin Heal reiterated a Buy rating on Intercontinental Exchange yesterday and set a price target of $190.00.

Memorial Day Sale – Claim 70% Off TipRanks

Heal covers the Financial sector, focusing on stocks such as Chubb, CME Group, and S&P Global. According to TipRanks, Heal has an average return of 11.2% and a 70.97% success rate on recommended stocks.

In a report released on May 13, Barclays also maintained a Buy rating on the stock with a $201.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Intercontinental Exchange’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $3.67 billion and a net profit of $1.41 billion. In comparison, last year the company earned a revenue of $3.23 billion and had a net profit of $797 million

Read More on ICE:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).